TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. - Anandhan S; Herbrich S; Goswami S; Guan B; Chen Y; Macaluso MD; Jindal S; Natarajan SM; Andrewes SW; Xiong L; Nagarajan A; Basu S; et al. (Nature communications, 2024)